Skip to main content

Futibatinib

(FYOO-tih-BA-tih-nib)

This page contains brief information about futibatinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Lytgobi
FDA Approved
Yes

FDA label information for this drug is available here.

Use in Cancer

Futibatinib is approved to treat:

  • Intrahepatic cholangiocarcinoma (cancer that forms in the bile ducts inside the liver) that has spread or cannot be removed with surgery. It is used in adults whose cancer has been treated and has an FGFR2 gene fusion or other change in the structure of the FGFR2 gene.

Futibatinib is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that it provides a clinical benefit in these patients.

Futibatinib is also being studied in the treatment of other types of cancer.

More About Futibatinib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Futibatinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: